New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2012
10:55 EDTPRAN
theflyonthewall.com: Prana receives FDA approval to commence Huntington's Disease trial
Prana Biotechnology announced that it has received approval from the United States Food and Drug Administration to start recruiting patients for the company's first clinical trial using PBT2 in patients with Huntington's Disease. Prana's Investigational New Drug Application is now open. The randomised, double-blind, placebo-controlled trial will enrol 100 patients with early to mid-stage Huntington's Disease. :theflyonthewall.com



News For PRAN From The Last 14 Days
Check below for free stories on PRAN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for these search parameters.